drugset / Trial / NCT05480462
Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.
RandomizedParallel-groupSingle-blindPrevention
Summary
A single blind, randomized, comparative, multicentre clinical trial of the immunogenicity and safety of booster immunization with bivalent vaccine against tetanus and diphtheria CLODIVAC (IBSS BIOMED S.A.) and Td-Impfstoff Mérieux (Sanofi Pasteur) in healthy adults.
Timeline
- Start
- 2022-12-12
- Primary completion
- 2024-03-04
- Completion
- 2024-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CLODIVAC | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Td-Impfstoff Merieux | Vaccine | 0.5 ml | Intramuscular |